gadolinium has been researched along with Diabetic Nephropathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, JC; Tata, AL; Wagner, LA | 1 |
| Canale, D; de Bragança, AC; Girardi, AC; Gois, PH; Luchi, WM; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
| Baumgarten, M; Gehr, T; Mirovski, M | 1 |
| Brown, M; High, WA; Jackson, BP; Lanzirotti, A; Punshon, T; Ranville, JF | 1 |
| Clément, O; Faye, N; Fournier, L; Frija, G; Siauve, N | 1 |
| Thomsen, HS | 1 |
| Ong, EM; Yeh, IB | 1 |
2 review(s) available for gadolinium and Diabetic Nephropathies
| Article | Year |
|---|---|
Patient safety issues in CKD: core curriculum 2015.
Topics: Acute Kidney Injury; Aged; Analgesics; Anemia; Anti-Bacterial Agents; Anticoagulants; Arrhythmias, Cardiac; Bacterial Infections; Contrast Media; Diabetic Nephropathies; Drug Interactions; Gadolinium; Glomerular Filtration Rate; Hematinics; Humans; Hyperkalemia; Hypoglycemic Agents; Insulin; Iodine Compounds; Kidney; Medication Errors; Metabolic Clearance Rate; Pain Management; Patient Safety; Pharmacokinetics; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2015 |
[Kidney and iodinated and gadolinium-based contrast agents].
Topics: Aged; Contrast Media; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fluid Therapy; Gadolinium; Glomerular Filtration Rate; Humans; Injections, Intra-Arterial; Injections, Intravenous; Iodine; Kidney Function Tests; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Pulmonary Embolism; Renal Insufficiency; Risk Assessment | 2011 |
5 other study(ies) available for gadolinium and Diabetic Nephropathies
| Article | Year |
|---|---|
Vitamin D deficiency is a potential risk factor for contrast-induced nephropathy.
Topics: Animals; Contrast Media; Diabetic Nephropathies; Disease Models, Animal; Gadolinium; Kidney; Kidney Diseases; Male; Oxidative Stress; Rats, Wistar; Risk Factors; Vitamin D; Vitamin D Deficiency | 2015 |
Progressive skin fibrosis.
Topics: Contrast Media; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diagnosis, Differential; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Skin; Skin Diseases | 2008 |
Gadolinium deposition in nephrogenic systemic fibrosis: an examination of tissue using synchrotron x-ray fluorescence spectroscopy.
Topics: Aged; Aged, 80 and over; Contrast Media; Diabetic Nephropathies; Eccrine Glands; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Spectrometry, Fluorescence; Synchrotrons | 2010 |
Gadolinium-based contrast media may be nephrotoxic even at approved doses.
Topics: Aged; Contrast Media; Diabetic Nephropathies; Diagnosis, Differential; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Humans; Kidney Function Tests; Magnetic Resonance Angiography; Male; Renal Artery Obstruction; Renal Insufficiency | 2004 |
High signal in the cerebrospinal fluid following prior gadolinium administration in a patient with renal impairment.
Topics: Aged; Brain; Contrast Media; Diabetic Nephropathies; Diagnosis, Differential; Female; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Metabolic Clearance Rate; Neurotoxicity Syndromes; Spinal Cord; Spinal Cord Diseases | 2007 |